Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Relationship Between Serum Neuregulin-4 (NRG4) Levels, Obesity Status, and Antidiabetic Treatment Regimens in Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study

NCT07734558 is registered in ClinicalTrials.gov with GÜLDEN ANATACA as lead sponsor.

NCT NCT07734558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07734558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Relationship Between Serum Neuregulin-4 (NRG4) Levels, Obesity Status, and Antidiabetic Treatment Regimens in Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study
Lead sponsor
GÜLDEN ANATACA
Phase
Observational
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
December 30, 2026
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, obesity type 2 diabetes mellitus, type 2 diabetes mellitus (t2dm)